BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

642 related articles for article (PubMed ID: 9468218)

  • 21. Differential regulation of E2F transactivation by cyclin/cdk2 complexes.
    Dynlacht BD; Flores O; Lees JA; Harlow E
    Genes Dev; 1994 Aug; 8(15):1772-86. PubMed ID: 7958856
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Deregulation of specific E2F complexes by the v-mos oncogene.
    Afshari CA; Rhodes N; Paules RS; Mudryj M
    Oncogene; 1997 Jun; 14(25):3029-38. PubMed ID: 9223666
    [TBL] [Abstract][Full Text] [Related]  

  • 23. C/EBPalpha regulates formation of S-phase-specific E2F-p107 complexes in livers of newborn mice.
    Timchenko NA; Wilde M; Darlington GJ
    Mol Cell Biol; 1999 Apr; 19(4):2936-45. PubMed ID: 10082561
    [TBL] [Abstract][Full Text] [Related]  

  • 24. BRCA1 proteins are transported to the nucleus in the absence of serum and splice variants BRCA1a, BRCA1b are tyrosine phosphoproteins that associate with E2F, cyclins and cyclin dependent kinases.
    Wang H; Shao N; Ding QM; Cui J; Reddy ES; Rao VN
    Oncogene; 1997 Jul; 15(2):143-57. PubMed ID: 9244350
    [TBL] [Abstract][Full Text] [Related]  

  • 25. E1A can provoke G1 exit that is refractory to p21 and independent of activating cdk2.
    Akli S; Zhan S; Abdellatif M; Schneider MD
    Circ Res; 1999 Aug; 85(4):319-28. PubMed ID: 10455060
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cyclin A/CDK2 binds directly to E2F-1 and inhibits the DNA-binding activity of E2F-1/DP-1 by phosphorylation.
    Xu M; Sheppard KA; Peng CY; Yee AS; Piwnica-Worms H
    Mol Cell Biol; 1994 Dec; 14(12):8420-31. PubMed ID: 7969176
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A unique domain of pRb2/p130 acts as an inhibitor of Cdk2 kinase activity.
    De Luca A; MacLachlan TK; Bagella L; Dean C; Howard CM; Claudio PP; Baldi A; Khalili K; Giordano A
    J Biol Chem; 1997 Aug; 272(34):20971-4. PubMed ID: 9261093
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A mutant E2F-1 transcription factor that affects the phenotype of NIH3T3 fibroblasts inefficiency associates with cyclin A-cdk2.
    Jordan-Sciutto KL; Hall DJ
    Biochem Cell Biol; 1998; 76(1):37-44. PubMed ID: 9666304
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Myc and Ras collaborate in inducing accumulation of active cyclin E/Cdk2 and E2F.
    Leone G; DeGregori J; Sears R; Jakoi L; Nevins JR
    Nature; 1997 May; 387(6631):422-6. PubMed ID: 9163430
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Regulation of the cdk inhibitor p21 gene during cell cycle progression is under the control of the transcription factor E2F.
    Hiyama H; Iavarone A; Reeves SA
    Oncogene; 1998 Mar; 16(12):1513-23. PubMed ID: 9569018
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Functions of cyclin A1 in the cell cycle and its interactions with transcription factor E2F-1 and the Rb family of proteins.
    Yang R; Müller C; Huynh V; Fung YK; Yee AS; Koeffler HP
    Mol Cell Biol; 1999 Mar; 19(3):2400-7. PubMed ID: 10022926
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Restoration of retinoblastoma mediated signaling to Cdk2 results in cell cycle arrest.
    Strobeck MW; Fribourg AF; Puga A; Knudsen ES
    Oncogene; 2000 Apr; 19(15):1857-67. PubMed ID: 10773875
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Collaborative role of E2F transcriptional activity and G1 cyclindependent kinase activity in the induction of S phase.
    Leone G; DeGregori J; Jakoi L; Cook JG; Nevins JR
    Proc Natl Acad Sci U S A; 1999 Jun; 96(12):6626-31. PubMed ID: 10359762
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Regulated ectopic expression of cyclin D1 induces transcriptional activation of the cdk inhibitor p21 gene without altering cell cycle progression.
    Hiyama H; Iavarone A; LaBaer J; Reeves SA
    Oncogene; 1997 May; 14(21):2533-42. PubMed ID: 9191053
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Phosphorylation of E2F-1 by cyclin A-cdk2.
    Kitagawa M; Higashi H; Suzuki-Takahashi I; Segawa K; Hanks SK; Taya Y; Nishimura S; Okuyama A
    Oncogene; 1995 Jan; 10(2):229-36. PubMed ID: 7838523
    [TBL] [Abstract][Full Text] [Related]  

  • 36. BCL-x(L) and BCL2 delay Myc-induced cell cycle entry through elevation of p27 and inhibition of G1 cyclin-dependent kinases.
    Greider C; Chattopadhyay A; Parkhurst C; Yang E
    Oncogene; 2002 Nov; 21(51):7765-75. PubMed ID: 12420213
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of pRB-family/E2F complex in the inhibition of IL-3-dependent lymphoid cell proliferation.
    Yamada M; Kondo T; Ashizawa S; Takebayashi T; Higashi H; Hatakeyama M
    Cytokine; 2002 Jan; 17(2):91-7. PubMed ID: 11886176
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transcription factor E2F and cyclin E-Cdk2 complex cooperate to induce chromosomal DNA replication in Xenopus oocytes.
    Akamatsu E; Tanaka T; Kato JY
    J Biol Chem; 1998 Jun; 273(26):16494-500. PubMed ID: 9632717
    [TBL] [Abstract][Full Text] [Related]  

  • 39. DP1 phosphorylation in multimeric complexes: weaker interaction with cyclin A through the E2F1 cyclin A binding domain leads to more efficient phosphorylation than stronger interaction through the p107 cyclin A binding domain.
    Guida P; Zhu L
    Biochem Biophys Res Commun; 1999 May; 258(3):596-604. PubMed ID: 10329431
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cyclin E and c-Myc promote cell proliferation in the presence of p16INK4a and of hypophosphorylated retinoblastoma family proteins.
    Alevizopoulos K; Vlach J; Hennecke S; Amati B
    EMBO J; 1997 Sep; 16(17):5322-33. PubMed ID: 9311992
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 33.